Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Treatment crawled time : 01:00 save search
Mass Flow Controllers Global Strategic Business Report 2024 - Mass Flow Controllers Gain Traction in Water & Wastewater Treatment Programs
Published: 2024-04-02 (Crawled : 01:00) - prnewswire.com
MKSI | $113.72 1.03% 1.02% 610K
|
Electronic Technology
|
| O: -1.96%
H: 0.05%
C: -0.38%
water report business treatment global flow
Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
AKBA | $1.36 -0.73% -0.74% 1.5M
|
Health Technology
|
| O: 10.27%
H: 0.4%
C: -25.91%
vafseo fda disease kidney anemia approval treatment dialysis
Everest Medicines Announces Singapore Health Sciences Authority Approves NEFEGAN® for the Treatment of Primary IgA Nephropathy in Adult Patients
Published: 2024-03-20 (Crawled : 01:00) - prnewswire.com
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: 1.43%
H: 0.0%
C: 0.0%
nefegan nephropathy health treatment sciences
Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting
Published: 2024-03-11 (Crawled : 01:00) - prnewswire.com
SGMT | News | $4.15 -3.04% -3.13% 220K
|
Health Technology
|
| O: 1.04%
H: 2.24%
C: -5.68%
asc40 presentation treatment meeting acne results study
Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Published: 2024-02-08 (Crawled : 01:00) - globenewswire.com
TENX | $3.51 0.29% 0.28% 7.9K
|
Health Technology
|
| O: -64.03%
H: 9.16%
C: -1.17%
tnx-103 first treatment hypertension heart therapeutics study
Global Atherectomy Devices Market Report 2023-2030: Minimally Invasive Treatment Options Surge in Demand, Key Players Boston Scientific, Abbott, and Medtronic Shape the Landscape
Published: 2024-01-09 (Crawled : 01:00) - prnewswire.com
TRUMF | $16.608 -17.59% 5.6K
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
TRUMY | $17.05 0.79% 47K
|
Manufacturing
|
| O: 4.99%
H: 0.29%
C: -2.67%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: -0.16%
H: 1.86%
C: 0.27%
ITGR | $123.27 4.55% 1.7% 1.1M
|
Producer Manufacturing
|
| O: -1.35%
H: 2.08%
C: 1.1%
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: -0.38%
H: 2.06%
C: 1.77%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: -0.22%
H: 1.1%
C: -3.78%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
report treatment global key market
Acute Ischemic Stroke Diagnosis and Treatment Market to Reach $9.2 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -1.89%
H: 0.0%
C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 1.19%
H: 3.09%
C: 1.3%
SYK | $336.85 0.58% 0.0% 1.5M
|
Health Technology
|
| O: 0.16%
H: 0.52%
C: -0.64%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 1.05%
H: 2.38%
C: 0.81%
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
|
| O: 4.96%
H: 1.5%
C: 0.91%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.21%
H: 0.27%
C: -0.52%
stroke reach treatment research market
CSL Behring's HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrates at Three Years Post-Treatment Long-Term Durability, Safety and Greater Bleed Protection Versus Prophylactic Treatment in People Living with Hemophilia B
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
QURE | $4.57 -3.79% -3.94% 640K
|
Health Technology
|
| O: 0.0%
H: 0.14%
C: 0.14%
hemgenix treatment living
Treatment with CARVYKTI® (ciltacabtagene autoleucel) Resulted in Clinically Meaningful Improvements in Health-Related Quality of Life and Reductions in Disease-Specific Symptoms in Patients with Earlier-Line Multiple Myeloma
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
carvykti life treatment
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: -0.2%
H: 1.7%
C: 1.3%
rient-16 treatment results study
Robot-Assisted Systems and Software Lead Robotic Dentistry Market, Offering Accurate and Efficient Dental Treatment Solutions
Published: 2023-11-02 (Crawled : 01:00) - prnewswire.com
NVST | $20.28 0.3% 0.0% 1.2M
|
Health Technology
|
| O: -11.92%
H: 8.4%
C: 4.94%
ISRG | $375.01 -0.55% -0.55% 1.3M
|
Health Technology
|
| O: 1.52%
H: 1.3%
C: 1.21%
ALGN | $313.95 0.66% 7.48% 1.1M
|
Health Technology
|
| O: 3.13%
H: 2.41%
C: 1.78%
software offering treatment dental solutions
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease
Published: 2023-10-02 (Crawled : 01:00) - prnewswire.com
FOLD 4 | $10.52 -1.77% -1.81% 1.6M
|
Health Technology
|
| O: -0.66%
H: 0.66%
C: -8.69%
fda disease approval treatment therapeutics
Wegener's Granulomatosis Treatment Market on the Rise: Increased Awareness and Advancements Drive Projected 5.9% CAGR Growth by 2031
Published: 2023-09-19 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.41%
H: 0.47%
C: 0.41%
SNOA | $0.155 -2.52% -2.58% 120K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.29%
HALO 4 | $39.095 0.32% 0.32% 620K
|
Health Technology
|
| O: 0.18%
H: 1.89%
C: 1.51%
treatment growth market
Global Alport Syndrome Treatment Market Set to Surge, Projected to Reach USD 19.00 Million by 2032
Published: 2023-08-31 (Crawled : 01:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
reach treatment global set market
Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy
Published: 2023-08-21 (Crawled : 01:00) - prnewswire.com
CALT | $18.5 1.65% 1.62% 1.5K
|
Health Technology
|
| O: 8.17%
H: 1.41%
C: -1.69%
nefecon fda nephropathy approval review treatment therapeutics
Global Biosimilars Market Analysis 2023 - 2030: Delivering Accessible Treatment Options and the Future of Healthcare
Published: 2023-08-16 (Crawled : 01:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.99%
H: 1.45%
C: 1.36%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 2.02%
H: 0.72%
C: -0.49%
treatment global market
United Kingdom Biocides Markets Report 2023-2028: From Water Treatment to Agriculture - Diverse End-Use Industries Fuels Market Growth
Published: 2023-08-09 (Crawled : 01:00) - prnewswire.com
ALB | News | $115.27 0.93% -0.23% 2.2M
|
Process Industries
|
| O: 0.94%
H: 0.0%
C: 0.0%
water report treatment agriculture growth market
Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published: 2023-07-17 (Crawled : 01:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: -1.28%
H: 4.55%
C: -0.65%
xpovio approval treatment
Global Hearing Loss Disease Treatment Market Report 2023: Rising Prevalence of Hearing Loss Drives Growth
Published: 2023-06-15 (Crawled : 01:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 1.04%
H: 0.78%
C: 0.67%
disease report treatment global growth market
Global Glioblastoma Multiforme (GBM) Treatment Market Report 2023: Increasing Prevalence of Brain Disorders is Expected to Propel Growth
Published: 2023-05-17 (Crawled : 01:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -1.32%
H: 0.92%
C: -1.34%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: -1.05%
FUSN | $21.4 -0.09% -0.09% 270K
|
Health Technology
|
| O: -1.54%
H: 1.34%
C: -2.67%
DFFN 4 | $6.6 11.68% -34.32% 350K
|
Health Technology
|
| O: -0.25%
H: 0.0%
C: -0.78%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.07%
H: 0.03%
C: -0.84%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.82%
H: 0.03%
C: -0.44%
propel report expected treatment global growth glioblastoma market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.